Public Health Department, University of KwaZulu-Natal, Durban, South Africa.
University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Copenhagen, Denmark.
PLoS One. 2020 Jun 4;15(6):e0232867. doi: 10.1371/journal.pone.0232867. eCollection 2020.
The Neglected Tropical Diseases Roadmap of the WHO set targets for potential elimination as a "public health problem" for the period 2012-2020 in multiple countries in Africa, with the aim of global elimination of schistosomiasis as a "public health problem" by 2025.
The purpose of the study was to estimate the cost from a provider's perspective of the Department of Health's Schistosomiasis Mass Drug Administration (MDA) in Ugu District, KwaZulu-Natal in 2012, with a view to project the costs for the entire KwaZulu Natal Province.
A total of 491 public schools and 16 independent schools in Ugu District, a predominantly rural district in KwaZulu-Natal with a total of 218 242 learners, were included in the schistosomiasis control programme. They were randomly selected from schools situated below an altitude of 300 meters, where schistosomiasis is endemic. A retrospective costing study was conducted using the provider's perspective to cost. Cost data were collected by reviewing existing records including financial statements, invoices, receipts, transport log books, equipment inventories, and information from personnel payroll, existing budget, and the staff diaries.
A total of 15571 children were treated in 2012, resulting in a total cost of the MDA programme of ZAR 2 137 143 and a unit cost of ZAR 137. The three main cost components were Medication Costs (37%), Human Resources Cost (36%) and Capital items (16%). The total cost for treating all eligible pupils in KwaZulu-Natal will be ZAR 149 031 888. However, should the capital cost be excluded, then the unit cost will be ZAR 112 per patient and this will translate to a total cost of ZAR 121 836 288.
Low coverage exacerbates the cost of the programme and makes a decision to support such a programme difficult. However, a normative costing study based on the integration of the programme within the Department of Health should be conducted.
世界卫生组织(WHO)的被忽视热带病路线图为多个非洲国家设定了在 2012-2020 年期间将血吸虫病作为“公共卫生问题”潜在消除的目标,目标是到 2025 年在全球消除血吸虫病作为“公共卫生问题”。
本研究旨在从提供者的角度估算 2012 年夸祖鲁-纳塔尔省乌古地区卫生局血吸虫病大规模药物治疗(MDA)的成本,以期预测整个夸祖鲁-纳塔尔省的成本。
乌古地区共有 491 所公立学校和 16 所独立学校纳入血吸虫病控制计划,该地区位于夸祖鲁-纳塔尔省,主要为农村地区,共有 218242 名学生。这些学校是从海拔 300 米以下的地方(血吸虫病流行地区)随机挑选出来的。采用提供者视角进行回顾性成本核算研究。成本数据是通过审查现有记录收集的,包括财务报表、发票、收据、运输日志、设备清单以及人员工资单、现有预算和工作人员日记中的信息。
2012 年共治疗了 15571 名儿童,MDA 项目总成本为 2137143 南非兰特,单位成本为 137 南非兰特。三个主要成本构成部分是药物成本(37%)、人力资源成本(36%)和资本项目(16%)。在夸祖鲁-纳塔尔省治疗所有符合条件的学生的总成本将为 149031888 南非兰特。但是,如果不包括资本成本,则每个患者的单位成本将为 112 南非兰特,总成本将为 121836288 南非兰特。
低覆盖率使该计划的成本增加,并使支持该计划的决策变得困难。但是,应该对该计划与卫生部整合后的规范成本进行研究。